{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3-Nitropropionic acid", "Huntington's disease", "Jyotishmati", "Malkangni"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28164735", "DateCompleted": {"Year": "2017", "Month": "03", "Day": "09"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/13880209.2017.1285945"], "Journal": {"ISSN": "1744-5116", "JournalIssue": {"Volume": "55", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Dec"}}, "Title": "Pharmaceutical biology", "ISOAbbreviation": "Pharm Biol"}, "ArticleTitle": "Ameliorating effect of Celastrus paniculatus standardized extract and its fractions on 3-nitropropionic acid induced neuronal damage in rats: possible antioxidant mechanism.", "Pagination": {"StartPage": "980", "EndPage": "990", "MedlinePgn": "980-990"}, "Abstract": {"AbstractText": ["Celastrus paniculatus Wild. (Celasteraceae) (CP) is a well-known Ayurvedic 'Medhya Rasayana' (nervine tonic), used extensively as a neuro-protective and memory enhancer, and in different central nervous system disorders.", "To evaluate the effect of CP against 3-nitropropionic acid (3-NP) induced Huntington's disease (HD) like symptoms in Wistar male rats.", "The ethanol extract of CP seeds (CPEE), prepared by maceration, was standardized on the basis of linoleic acid content (6.42%) using thin layer chromatography densitometric analysis. Protective effect of CPEE (100 and 200\u2009mg/kg) and its various fractions, viz., petroleum ether (40\u2009mg/kg), ethyl acetate (2.5\u2009mg/kg), n-butanol (7\u2009mg/kg) and aqueous (18\u2009mg/kg), administered orally for 20 days, against 3-NP (10\u2009mg/kg, i.p. for 14 days) was assessed by their effect on body weight, locomotor activity, grip strength, gait pattern and cognitive dysfunction and biochemical parameters for oxidative damage in the striatum and cortex regions of the brain.", "CPEE (100 and 200\u2009mg/kg) treated animals exhibited a significant (p\u2009<\u20090.05) improvement in behavioural and oxidative stress parameters in comparison to only 3-NP treated animals. Amongst various tested fractions of CPEE, aqueous fraction (AF) at 18\u2009mg/kg exhibited maximum reversal of 3-NP induced behavioural and biochemical alterations, and was therefore also tested at 9 and 36\u2009mg/kg. CPEE (100\u2009mg/kg) and AF (36\u2009mg/kg) exhibited maximum and significant (p\u2009<\u20090.05) attenuation of 3-NP induced alterations in comparison to 3-NP treated rats.", "CPEE has a protective action against 3-NP induced HD like symptoms due to its strong antioxidant effect."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a University Institute of Pharmaceutical Sciences - Centre of Advanced Study, Panjab University , Chandigarh , India."}], "LastName": "Malik", "ForeName": "Jai", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a University Institute of Pharmaceutical Sciences - Centre of Advanced Study, Panjab University , Chandigarh , India."}], "LastName": "Karan", "ForeName": "Maninder", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a University Institute of Pharmaceutical Sciences - Centre of Advanced Study, Panjab University , Chandigarh , India."}], "LastName": "Dogra", "ForeName": "Rachna", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pharm Biol", "NlmUniqueID": "9812552", "ISSNLinking": "1388-0209"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Nitro Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Propionates"}, {"RegistryNumber": "0", "NameOfSubstance": "Solvents"}, {"RegistryNumber": "3K9958V90M", "NameOfSubstance": "Ethanol"}, {"RegistryNumber": "QY4L0FOX0D", "NameOfSubstance": "3-nitropropionic acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": ["metabolism"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["drug effects", "metabolism", "pathology", "physiopathology"], "DescriptorName": "Brain"}, {"QualifierName": ["chemistry"], "DescriptorName": "Celastrus"}, {"QualifierName": [], "DescriptorName": "Chromatography, Thin Layer"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cognition"}, {"QualifierName": [], "DescriptorName": "Cytoprotection"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ethanol"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gait"}, {"QualifierName": ["metabolism", "physiopathology", "prevention & control", "psychology"], "DescriptorName": "Huntington Disease"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Memory"}, {"QualifierName": ["drug effects"], "DescriptorName": "Motor Activity"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Strength"}, {"QualifierName": [], "DescriptorName": "Nerve Degeneration"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Neurons"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Nitro Compounds"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Propionates"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Seeds"}, {"QualifierName": ["chemistry"], "DescriptorName": "Solvents"}, {"QualifierName": [], "DescriptorName": "Time Factors"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Ahmad F, Khan RA, Rasheed S.. 1994. Preliminary screening of methanolic extracts of Celastrus paniculatus and Tecomella undulata for analgesic and anti-inflammatory activities. J Ethnopharmacol. 42:193\u2013198.", "ArticleIdList": ["7934089"]}, {"Citation": "Andre VM, Cepeda C, Levine MS.. 2010. Dopamine and glutamate in Huntington's disease: a balancing act. CNS Neurosci Ther. 16:163\u2013178.", "ArticleIdList": ["PMC3118459", "20406248"]}, {"Citation": "Aziz NA, Van Der Burg JMM, Landwehrmeyer GB, Brundin P, Stijnen T, Roos RAC, Group ES.. 2008. Weight loss in Huntington disease increases with higher CAG repeat number. Neurology. 71:1506\u20131513.", "ArticleIdList": ["18981372"]}, {"Citation": "Badrul A, Ekramul H.. 2011. Anti-Alzheimer and antioxidant activity of Celastrus paniculatus seed. Iran J Pharm Sci. 7:49\u201356."}, {"Citation": "Bhanumathy M, Chandrasekar SB, Chandur U, Somasundaram T.. 2010a. Phyto-pharmacology of Celastrus paniculatus: an overview. Int J Pharm Sci Rev Res. 2:176\u2013181."}, {"Citation": "Bhanumathy M, Harish MS, Shivaprasad HN, Sushma G.. 2010b. Nootropic activity of Celastrus paniculatus seed. Pharm Biol. 48:324\u2013327.", "ArticleIdList": ["20645820"]}, {"Citation": "Bidwai PP, Wangoo D, Bhullar NK.. 1990. Antispermatogenic action of Celastrus paniculatus seed extract in the rat with reversible changes in the liver. J Ethnopharmacol. 28:293\u2013303.", "ArticleIdList": ["2335957"]}, {"Citation": "Chakraborty J, Singh R, Dutta D, Naskar A, Rajamma U, Mohanakumar KP.. 2014. Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington's disease. CNS Neurosci Ther. 20:10\u201319.", "ArticleIdList": ["PMC6493046", "24188794"]}, {"Citation": "Djousse L, Knowlton B, Cupples LA, Marder K, Shoulson I, Myers RH.. 2002. Weight loss in early stage of Huntington's disease. Neurology. 59:1325\u20131330.", "ArticleIdList": ["12427878"]}, {"Citation": "Dong X, Wang Y, Qin Z.. 2009. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin. 30:379\u2013387.", "ArticleIdList": ["PMC4002277", "19343058"]}, {"Citation": "Ellman GL.1959. Tissue sulfhydryl groups. Arch Biochem Biophys. 82:70\u201377.", "ArticleIdList": ["13650640"]}, {"Citation": "Frank S.2014. Treatment of Huntington's disease. Neurotherapeutics. 11:153\u2013160.", "ArticleIdList": ["PMC3899480", "24366610"]}, {"Citation": "Gattu M, Boss LK, Terry VA, Buccafusco JJ.. 1997. Reversal of scopolamine-induced deficits in navigational performance by the seed oil of Celastrus paniculatus. Pharmacol Biochem Behav. 57:793\u2013799.", "ArticleIdList": ["9259008"]}, {"Citation": "Gil-Mohapel J, Brocardo PS, Christie BR.. 2014. The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates? Curr Drug Targets. 15:454\u2013468.", "ArticleIdList": ["24428525"]}, {"Citation": "Godkar PB, Gordon RK, Ravindran A, Doctor BP.. 2003. Celastrus paniculatus seed water soluble extracts protect cultured rat forebrain neuronal cells from hydrogen peroxide-induced oxidative injury. Fitoterapia. 74:658\u2013669.", "ArticleIdList": ["14630170"]}, {"Citation": "Godkar PB, Gordon RK, Ravindran A, Doctor BP.. 2004. Celastrus paniculatus seed water soluble extracts protect against glutamate toxicity in neuronal cultures from rat forebrain. J Ethnopharmacol. 93:213\u2013219.", "ArticleIdList": ["15234755"]}, {"Citation": "Godkar PB, Gordon RK, Ravindran A, Doctor BP.. 2006. Celastrus paniculatus seed oil and organic extracts attenuate hydrogen peroxide- and glutamate-induced injury in embryonic rat forebrain neuronal cells. Phytomedicine. 13:29\u201336.", "ArticleIdList": ["16360930"]}, {"Citation": "Gopinath K, Sudhandiran G.. 2012. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience. 227:134\u2013143.", "ArticleIdList": ["22871521"]}, {"Citation": "Gornall AG, Bardawill CJ, David MM.. 1949. Determination of serum proteins by means of the biuret reaction. J Biol Chem. 177:751\u2013766.", "ArticleIdList": ["18110453"]}, {"Citation": "Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR.. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem. 126:131\u2013138.", "ArticleIdList": ["7181105"]}, {"Citation": "Hertog HJ, Hackman TJ, Nanavati DD, Dev S.. 1973. Malkanguniol, one of the polyalcohols from Celastrus paniculatus Willd. Tetrahedron Lett. 11:845\u2013848."}, {"Citation": "Johri A, Beal MF.. 2012. Antioxidants in Huntington's disease. Biochim Biophys Acta. 1822:664\u2013674.", "ArticleIdList": ["PMC3303936", "22138129"]}, {"Citation": "Kono Y.1978. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase . Arch Biochem Biophys. 186:189\u2013195.", "ArticleIdList": ["24422"]}, {"Citation": "Krobitsch S, Kazantsev AG.. 2011. Huntington's disease: from molecular basis to therapeutic advances . Int J Biochem Cell Biol. 43:20\u201324.", "ArticleIdList": ["21056115"]}, {"Citation": "Kumar MHV, Gupta YK.. 2002. Antioxidant property of Celastrus paniculatus Willd.: a possible mechanism of enhancing cognition. Phytomedicine. 9:302\u2013311.", "ArticleIdList": ["12120811"]}, {"Citation": "Kumar P, Kumar A.. 2009a. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food. 12:591\u2013600.", "ArticleIdList": ["19627208"]}, {"Citation": "Kumar P, Kumar A.. 2009b. Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms. Psychopharmacology. 207:257\u2013270.", "ArticleIdList": ["19763544"]}, {"Citation": "Kumar P, Kumar A.. 2010. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behav Brain Res. 206:38\u201346.", "ArticleIdList": ["19716383"]}, {"Citation": "Kumar P, Padi SSV, Naidu PS, Kumar A.. 2006. Protective effect of antioxidants on 3-nitropropionic acid induced oxidative stress and cognitive impairment. Ann Neurosci. 13:41\u201347."}, {"Citation": "Lekha G, Kumar BP, Rao SN, Arockiasamy I, Mohan K.. 2010. Cognitive enhancement and Neuroprotective effect of Celastrus paniculatus Willd. seed oil (Jyothismati oil) on male Wistar rats. J Pharm Sci Technol. 2:130\u2013138."}, {"Citation": "Luck H.1971. Catalase In: Bergmeyer HU, editor. Methods of enzymatic analysis. New York: Academic Press; p. 885\u2013893."}, {"Citation": "Malik J, Choudhary S, Kumar P.. 2015. Protective effect of Convolvulus pluricaulis standardized extract and its fractions against 3-nitropropionic acid-induced neurotoxicity in rats. Pharm Biol. 53:1448\u20131457.", "ArticleIdList": ["25853968"]}, {"Citation": "Mittal SK, Eddy C.. 2013. The role of dopamine and glutamate modulation in Huntington disease. Behav Neurol. 26:255\u2013263.", "ArticleIdList": ["PMC5215439", "22713410"]}, {"Citation": "Nadkarni KM.2002. Indian Materia Medica. New Delhi: Popular Prakashan Pvt. Ltd."}, {"Citation": "Nalini K, Karnath KS, Rao A, Aroor AR.. 1995. Effects of Celastrus paniculatus on passive avoidance performance and biogenic amine turnover in albino rats. J Ethnopharmacol. 47:101\u2013108.", "ArticleIdList": ["7500635"]}, {"Citation": "Palmer GC.2001. Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Curr Drug Targets. 2:241\u2013271.", "ArticleIdList": ["11554551"]}, {"Citation": "Perez-De La Cruz V, Elinos-Calderon D, Robledo-Arratia Y, Medina-Campos ON, Pedraza-Chaverri J, Ali SF, Santamaria A.. 2009. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease. Behav Brain Res. 199:210\u2013217.", "ArticleIdList": ["19100293"]}, {"Citation": "Picconi B, Passino E, Sgobio C, Bonsi P, Barone I, Ghiglieri V, Pisani A, Bernardi G, Ammassari-Teule M, Calabresi P.. 2006. Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons. Neurobiol Dis. 22:143\u2013152.", "ArticleIdList": ["16326108"]}, {"Citation": "Rajkumar R, Kumar EP, Sudha S, Suresh B.. 2007. Evaluation of anxiolytic potential of Celastrus oil in rat models of behaviour. Fitoterapia. 78:120\u2013124.", "ArticleIdList": ["17169502"]}, {"Citation": "Saydoff JA, Liu LS, Garcia RA, Hu Z, Li D, von Borstel RW.. 2003. Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. Brain Res. 994:44\u201354.", "ArticleIdList": ["14642447"]}, {"Citation": "Shinomol GK, Muralidhara. 2011. Bacopa monnieri modulates endogenous cytoplasmic and mitochondrial oxidative markers in prepubertal mice brain. Phytomedicine. 18:317\u2013326.", "ArticleIdList": ["20850955"]}, {"Citation": "Silva RH, Abilio VC, Kameda SR, Takatsu-Coleman AL, Carvalho RC, Ribeiro Rde A, Tufik S, Frussa-Filho R.. 2007. Effects of 3-nitropropionic acid administration on memory and hippocampal lipid peroxidation in sleep-deprived mice. Prog Neuropsychopharmacol Biol Psychiatry. 31:65\u201370.", "ArticleIdList": ["16876303"]}, {"Citation": "Sugino T, Nozaki K, Takagi Y, Hattori I, Hashimoto N, Yodoi J.. 1999. Expression and distribution of redox regulatory protein, thioredoxin after metabolic impairment by 3-nitropropionic acid in rat brain. Neurosci Lett. 275:145\u2013148.", "ArticleIdList": ["10568520"]}, {"Citation": "Tandon N, Sharma P.. 2011. Quality standards of Indian medicinal plants. New Delhi: Medicinal Plants Unit, Indian Council of Medical Research."}, {"Citation": "Tu YQ, Chen YZ.. 1993. Sesquiterpenoids from Celastrus paniculatus. J Nat Prod. 56:122\u2013125."}, {"Citation": "Tu YQ, Wu TX, Li ZZ, Zhen T, Chen YZ.. 1991. Sesquiterpene polyol esters from Celastrus paniculatus. J Nat Prod. 54:1383\u20131386."}, {"Citation": "Tunez I, Santamaria A.. 2009. Model of Huntington's disease induced with 3-nitropropionic acid. Rev Neurol. 48:430\u2013434.", "ArticleIdList": ["19340784"]}, {"Citation": "Tunez I, Tasset I, Cruz VPL, Santamaria A.. 2010. 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. Molecules. 15:878\u2013916.", "ArticleIdList": ["PMC6263191", "20335954"]}, {"Citation": "Wagner H, Heckkel E, Sonnenbichler J.. 1974. Isolation and structures of a new sesquiterpene (malkangunin) and two new sesquiterpene alkaloids (celapanin, celapanigin) from Celastrus paniculatus Willd. Tetrahedron Lett. 2:213\u2013216."}, {"Citation": "Wills ED.1966. Mechanisms of lipid peroxide formation in animal tissues. Biochem J. 99:667\u2013676.", "ArticleIdList": ["PMC1265056", "5964963"]}]}], "History": [{"Year": "2017", "Month": "2", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "2", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28164735", "PMC6130694", "10.1080/13880209.2017.1285945"]}}]}